Journal
/
/
Behandling SCA1 Mus med vannløselige forbindelser til ikke-spesifikt Boost mitokondrienes funksjon
Journal JoVE
Médecine
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Médecine
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
DOI:

11:47 min

January 22, 2017

, , , , , , , , ,

Chapitres

  • 00:05Titre
  • 01:25Footprint Analysis
  • 03:00Beam Analysis
  • 04:16Accelerating Rotarod
  • 05:35Immunopathology Assay
  • 09:39Results: Treatment Scheme and Representative Data from the Footprint Assay, Beam Assay and Accelerating Rotarod
  • 10:59Conclusion

Summary

Traduction automatique

We present a biochemical and behavioral protocol to evaluate the efficacy of mitochondria-targeted water-soluble compounds for the treatment of Spinocerebellar ataxia type 1 (SCA1) and other cerebellar neurodegenerative diseases.

Vidéos Connexes

Read Article